These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

293 related items for PubMed ID: 24297388

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Performance of (18)F-FDG PET/CT as a postoperative surveillance imaging modality for asymptomatic advanced gastric cancer patients.
    Lee DY, Lee CH, Seo MJ, Lee SH, Ryu JS, Lee JJ.
    Ann Nucl Med; 2014 Oct; 28(8):789-95. PubMed ID: 24965850
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. PET/Computed Tomography in the Diagnosis and Staging of Gastric Cancers.
    Malibari N, Hickeson M, Lisbona R.
    PET Clin; 2015 Jul; 10(3):311-26. PubMed ID: 26099669
    [Abstract] [Full Text] [Related]

  • 7. Evaluation of 18F-2-deoxy-2-fluoro-D-glucose positron emission tomography for gastric cancer.
    Mochiki E, Kuwano H, Katoh H, Asao T, Oriuchi N, Endo K.
    World J Surg; 2004 Mar; 28(3):247-53. PubMed ID: 14961197
    [Abstract] [Full Text] [Related]

  • 8. Quantitative volumetric CT-histogram analysis in N-staging of 18F-FDG-equivocal patients with lung cancer.
    Flechsig P, Kratochwil C, Schwartz LH, Rath D, Moltz J, Antoch G, Heussel CP, Rieser M, Warth A, Zabeck H, Kauczor HU, Haberkorn U, Giesel FL.
    J Nucl Med; 2014 Apr; 55(4):559-64. PubMed ID: 24525209
    [Abstract] [Full Text] [Related]

  • 9. Usefulness of combined PET/CT to assess regional lymph node involvement in gastric cancer.
    Park K, Jang G, Baek S, Song H.
    Tumori; 2014 Apr; 100(2):201-6. PubMed ID: 24852866
    [Abstract] [Full Text] [Related]

  • 10. FDG-PET/CT for the preoperative lymph node staging of invasive bladder cancer.
    Swinnen G, Maes A, Pottel H, Vanneste A, Billiet I, Lesage K, Werbrouck P.
    Eur Urol; 2010 Apr; 57(4):641-7. PubMed ID: 19477579
    [Abstract] [Full Text] [Related]

  • 11. The peak-standardized uptake value (P-SUV) by preoperative positron emission tomography-computed tomography (PET-CT) is a useful indicator of lymph node metastasis in gastric cancer.
    Oh HH, Lee SE, Choi IS, Choi WJ, Yoon DS, Min HS, Ra YM, Moon JI, Kang YH.
    J Surg Oncol; 2011 Oct; 104(5):530-3. PubMed ID: 21618250
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Lymph node staging by positron emission tomography in cervical cancer: relationship to prognosis.
    Kidd EA, Siegel BA, Dehdashti F, Rader JS, Mutch DG, Powell MA, Grigsby PW.
    J Clin Oncol; 2010 Apr 20; 28(12):2108-13. PubMed ID: 20308664
    [Abstract] [Full Text] [Related]

  • 14. Improvement in preoperative staging of gastric adenocarcinoma with positron emission tomography.
    Chen J, Cheong JH, Yun MJ, Kim J, Lim JS, Hyung WJ, Noh SH.
    Cancer; 2005 Jun 01; 103(11):2383-90. PubMed ID: 15856477
    [Abstract] [Full Text] [Related]

  • 15. Role of FDG-PET in the assessment of survival prognosis in melanoma.
    Pleiss C, Risse JH, Biersack HJ, Bender H.
    Cancer Biother Radiopharm; 2007 Dec 01; 22(6):740-7. PubMed ID: 18158764
    [Abstract] [Full Text] [Related]

  • 16. Prognostic value of metabolic tumor burden from (18)F-FDG PET in surgical patients with non-small-cell lung cancer.
    Zhang H, Wroblewski K, Liao S, Kampalath R, Penney BC, Zhang Y, Pu Y.
    Acad Radiol; 2013 Jan 01; 20(1):32-40. PubMed ID: 22999369
    [Abstract] [Full Text] [Related]

  • 17. Predictive Role of the Number of 18F-FDG-Positive Lymph Nodes Detected by PET/CT for Pre-Treatment Evaluation of Locally Advanced Gastric Cancer.
    Wang X, Wei Y, Xue Y, Lu P, Yu L, Shen B.
    PLoS One; 2016 Jan 01; 11(12):e0166836. PubMed ID: 27936109
    [Abstract] [Full Text] [Related]

  • 18. A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer.
    Kauhanen SP, Komar G, Seppänen MP, Dean KI, Minn HR, Kajander SA, Rinta-Kiikka I, Alanen K, Borra RJ, Puolakkainen PA, Nuutila P, Ovaska JT.
    Ann Surg; 2009 Dec 01; 250(6):957-63. PubMed ID: 19687736
    [Abstract] [Full Text] [Related]

  • 19. Contrast-enhanced [(18)F]fluorodeoxyglucose-positron emission tomography/computed tomography for staging and radiotherapy planning in patients with anal cancer.
    Bannas P, Weber C, Adam G, Frenzel T, Derlin T, Mester J, Klutmann S.
    Int J Radiat Oncol Biol Phys; 2011 Oct 01; 81(2):445-51. PubMed ID: 20832181
    [Abstract] [Full Text] [Related]

  • 20. Diagnostic accuracy of (18)F-2-deoxy-fluoro-D-glucose positron emission tomography for pN2 lymph nodes in patients with lung cancer.
    Ozawa Y, Hara M, Sakurai K, Nakagawa M, Tamaki T, Nishio M, Shibamoto Y.
    Acta Radiol; 2010 Mar 01; 51(2):150-5. PubMed ID: 20092375
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.